Tumor markers (carcinoembryonic antigen (CEA) and carbohydrate 19–9 antigen (CA 19–9)) constitute a prognostic element and are used for post-therapeutic surveillance of colorectal cancers to increase the chances of detecting recurrences at a stage where they are operable [5,25,26]. Here, CEACAM5 is linked to colorectal cancer.